- Home
- TOPS vs PYPD Comparison
TOPS vs PYPD Comparison
Compare TOPS & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOPS
- PYPD
- Stock Information
- Founded
- TOPS 2000
- PYPD 2008
- Country
- TOPS Greece
- PYPD Israel
- Employees
- TOPS N/A
- PYPD N/A
- Industry
- TOPS Marine Transportation
- PYPD Medical/Dental Instruments
- Sector
- TOPS Consumer Discretionary
- PYPD Health Care
- Exchange
- TOPS Nasdaq
- PYPD Nasdaq
- Market Cap
- TOPS 28.3M
- PYPD 30.1M
- IPO Year
- TOPS 2004
- PYPD 2020
- Fundamental
- Price
- TOPS $6.46
- PYPD $2.71
- Analyst Decision
- TOPS
- PYPD Strong Buy
- Analyst Count
- TOPS 0
- PYPD 2
- Target Price
- TOPS N/A
- PYPD $10.50
- AVG Volume (30 Days)
- TOPS 8.7K
- PYPD 12.4K
- Earning Date
- TOPS 04-15-2025
- PYPD 05-07-2025
- Dividend Yield
- TOPS N/A
- PYPD N/A
- EPS Growth
- TOPS N/A
- PYPD N/A
- EPS
- TOPS N/A
- PYPD N/A
- Revenue
- TOPS $83,870,000.00
- PYPD N/A
- Revenue This Year
- TOPS $7.10
- PYPD N/A
- Revenue Next Year
- TOPS $6.54
- PYPD N/A
- P/E Ratio
- TOPS N/A
- PYPD N/A
- Revenue Growth
- TOPS 1.10
- PYPD N/A
- 52 Week Low
- TOPS $5.30
- PYPD $2.37
- 52 Week High
- TOPS $14.24
- PYPD $5.09
- Technical
- Relative Strength Index (RSI)
- TOPS 63.70
- PYPD 42.57
- Support Level
- TOPS $6.33
- PYPD $2.66
- Resistance Level
- TOPS $6.54
- PYPD $2.75
- Average True Range (ATR)
- TOPS 0.19
- PYPD 0.12
- MACD
- TOPS 0.05
- PYPD -0.01
- Stochastic Oscillator
- TOPS 74.47
- PYPD 11.48
About TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The company focuses on the transportation of petroleum products (clean and dirty) and bulk liquid chemicals. The Company is an international provider of worldwide oil, petroleum products and chemical transportation services. It generates revenue from the Time Charter agreements.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.